Abstract
Natural killer (NK) cells are a critical component of the innate immune system, known for their ability to target and kill tumor cells without prior sensitization. This article explores the role of NK cells in cancer immunotherapy, focusing on their mechanisms of action, the challenges of harnessing their potential in cancer treatment, and the latest advances in NK cell-based therapies. It also examines the interactions between NK cells and the tumor microenvironment, highlighting the factors that influence NK cell activity in cancerous tissues. The article concludes with a discussion on the therapeutic strategies being developed to enhance NK cell efficacy in cancer immunotherapy.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2022 Dr. Benjamin Clark (Author)